Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi's sarcoma (KS), intravenously (i.v.) injected human mesenchymal stem cells (MSCs) home to sites of tumorigenesis and potently inhibit tumor growth. We further show that human MSCs can inhibit the in vitro activation of the Akt protein kinase within some but not all tumor and primary cell lines. The inhibition of Akt activity requires the MSCs to make direct cell–cell contact and can be inhibited by a neutralizing antibody against E-cadherin. We further demonstrate that in vivo, Akt activation within KS cells is potently down-regulated in areas adjacent to MSC infiltration. Finally, the in vivo tumor-suppressive effects of MSCs correlates with their ability to inhibit target cell Akt activity, and KS tumors engineered to express a constitutively activated Akt construct are no longer sensitive to i.v. MSC administration. These results suggest that in contrast to other stem cells or normal stromal cells, MSCs possess intrinsic antineoplastic properties and that this stem cell population might be of particular utility for treating those human malignancies characterized by dysregulated Akt.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“There they can potentiate further tumorigenesis via differentiation into tumor-nurturing stroma (TAF, myofibroblasts) [82, 104], direct cell contact interaction with cancer cells [105, 106] or release of paracrine factors (Table 2).”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [106]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The anti-tumorigenic and pro-apoptotic effect of MSCs results from the suppression of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) signaling pathway in some cancer types [59].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Existing data from pre-clinical studies regarding the pro-apoptotic effect of MSCs on cancer cells through the downregulation of PI3K/Akt pathway support this antitumor potential in hepatocellular carcinoma, glioma cells, Kaposi's sarcoma, and prostate and breast cancer [61], [62], [63], [64], [65].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [61]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,654
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436 · cited 1×
“The myristoylated Akt plasmid (myrAkt) has been previously described (49)”
BackgroundStromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., & Chopp, M. (2001) · Stroke · doi:10.1161/01.str.32.4.1005 · Cited by 1,764
Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., & Ringdén, O. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00110-3 · Cited by 1,623
Cited by
Items 701–747 of 747
Mesenchymal Stem Cells as a Carrier for Targeting Anti-Tumor Therapeutics
Wu, J. (2013) · eScholarship (California Digital Library)
Mesenchymal stem cells in inflammatory bowel disease and cancer
Miller, S. (2017) · Victoria University Research Repository (Victoria University)
Interaction of Human Dental Pulp Stem Cells and Ameloblastic Cell In-vitro- A Preclinical Analysis
Manimaran, K., Kumar, A., AvinashGandi, D., & Sankaranarayanan, S. (2018) · Annals of Oral Health and Dental Research · doi:10.21276/aohdr.1831
Mesenchymal Stem Cells in Laryngopharyngeal Cancer
Park, Y., Lee, B., & Shin, S. (2014) · Journal of Clinical Otolaryngology Head and Neck Surgery · doi:10.35420/jcohns.2014.25.2.137
Herheliuk, T., Perepelytsina, O. M., Остапченко, Л. І., & Sydorenko, M. V. (2018) · Cytology and Genetics · doi:10.3103/s0095452718040035
Multipotent Stromal Cells in a Tumor Microenvironment
Bruna, F. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77345
The role of human bone marrow mesenchymal stromal cells in pancreatic cancer growth
Antoon, R. (2017) · TSpace (University of Toronto)
Weeratunga, P. (2020) · The University of Queensland · doi:10.14264/uql.2020.749
Patra, S. S. (2020) · doi:10.37421/2168-9547.2020.09.250
Aoki, M., Kakimoto, K., Goto, M., & Higuchi, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-99148-5
RetractedMSC Therapy in Animal Models and in Regenerative Medicine for Human Diseases
Zipori, D. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-130-1_8
Mesenchymal stem cells for therapeutic application in corneal transplantation
Treacy, O. (2014) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17328
Therapeutic Strategies for ROS-Dependent Tumor Angiogenesis Using Vascular Stem Cells
Bhagavatheeswaran, S., & Balakrishnan, A. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_106-1
van Buul, G. M., & van Osch, G. J. V. M. (2013) · Springer eBooks · doi:10.1007/978-94-007-5690-8_17
Faculty Opinions recommendation of Ethical and Safety Issues of Stem Cell-Based Therapy.
Millar, N. L. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732466979.793579465
Diagnostic and Therapeutic Mesenchymal Stem Cells for Breast Cancer Treatment
Dwyer, R. M. (2013) · Wiley eBooks · doi:10.1002/9781118660423.ch11 · Cited by 1
Rodríguez-Pardo, V. M. (2020) · Repositorio Institucional (Pontificia Universidad Javeriana) · doi:10.11144/javeriana.10554.11764
Considerations for Clinical Use of Mesenchymal Stromal Cells
Hmadcha, A., Soria, B., Tejedo, J. R., Bedoya, F. J., Sempere-Ortells, J. M., & Smani, T. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_3-1
Therapeutic Strategies for ROS-Dependent Tumor Angiogenesis Using Vascular Stem Cells
Bhagavatheeswaran, S., & Balakrishnan, A. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_106
Considerations for Clinical Use of Mesenchymal Stromal Cells
Hmadcha, A., Soria, B., Tejedo, J. R., Bedoya, F. J., Sempere-Ortells, J. M., & Smani, T. (2022) · Springer eBooks · doi:10.1007/978-981-19-2655-6_3
Yüce, M. (2023) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.40.1.32
Mohammadi, R., Fazeli, Z., Daraei, A., & Asgari, K. (2023) · Research Square · doi:10.21203/rs.3.rs-2747024/v1
Multifunctional hybrid hydrogel for the prevention of post-surgery tumor recurrence.
Paresishvili, T., Janelidze, M., & Kakabadze, Z. (2023) · PubMed Central · Cited by 2
Mohammadi, R., Fazeli, Z., Daraei, A., & Asgari, K. (2023) · Research Square · doi:10.21203/rs.3.rs-3246688/v1
Yüce, M., Albayrak, E., & Gümüşkaptan, Ç. (2023) · Anatolian Current Medical Journal · doi:10.38053/acmj.1359905
Al-Toub, M., Alhamid, A. S., Aldahmash, B. A., Rady, A. M., & El-Hashash, A. H. K. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4675577
Pro- and Anti-Cancer Behaviors of Mesenchymal Stem Cells
Abu-Shahba, N., Kiwan, H. S., & ElHefnawi, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00128-1
Mohammadi, R., Fazeli, Z., Daraei, A., & Asgari, K. (2025) · International Journal of Cancer Management · doi:10.5812/ijcm-160152
The Effect of Stem Cells on the Treatment of Undifferentiated Pleomorphic Sarcoma
Gallicchio, V. S. (2025) · Journal of Regenerative Medicine and Biology Research · doi:10.46889/jrmbr.2024.6203
Cancer Metastasis: Dynamic Hetero-cellular Communications Between Cancer Cells and Host Tissues
Saliba, J. L., El-Sabban, M., Shaito, A. A., El-Harakeh, M., Obeid, J., Hajj, H. E., & El-Sabban, M. E. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_57
Cheng, J.-W., Duan, L.-X., Yu, Y., Wang, P., Feng, J.-L., Feng, G., & Liu, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14609059
Yu, J.-L., Chan, S., Fung, M. K.-L., & Chan, G. C.-F. (2021) · Figshare · doi:10.6084/m9.figshare.14398335
Cheng, J.-W., Duan, L.-X., Yu, Y., Wang, P., Feng, J.-L., Feng, G.-Z., & Liu, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14609053
Cheng, J.-W., Duan, L.-X., Yu, Y., Wang, P., Feng, J.-L., Feng, G.-Z., & Liu, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14609056
Hu, W., Wang, W., Jiang, X., Wang, Z., & Lin, R. (2024) · Figshare · doi:10.6084/m9.figshare.26578349
Hu, W., Wang, W., Jiang, X., Wang, Z., & Lin, R. (2024) · Figshare · doi:10.6084/m9.figshare.26578352
Multipotent Mesenchymal Stromal Cells - A Promising Cytotherapeutic Agent for Breast Cancer
Srinivasan, S., Ghone, N. V., Jayaraman, H., & Ashok, M. A. (2026) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x398024250926100803
Escobar, P. A. (2010) · theses.fr (ABES) · doi:10.70675/6ef77dc7ze8f2z4d7bza761zc1f42658f0a5
Belmokhtar, K. (2011) · theses.fr (ABES) · doi:10.70675/d4872c56z5bd5z40c9zba80z894bbfbb32fa
Metabolic Mayhem in the Tumor Microenvironment: Can Mesenchymal Stromal Cells Restore Order?
Abou‐Shanab, A. M., Khairy, A., Hany, F., & El‐Badri, N. (2026) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-032-12705-1_8
Développement d'une stratégie Cheval de Troie dans le traitement du carcinome hépatocellulaire
Nayagom, B. (2019) · theses.fr (ABES) · doi:10.70675/780d49f6zde47z4ff1z9bc4z7e014070104c
Activation des lymphocytes T gamma delta dans les cancers
Laplagne, C. (2020) · theses.fr (ABES) · doi:10.70675/7f8ae6ddz0e42z4c41z838fz044b72328b9c
Gargiulo, E. (2021) · theses.fr (ABES) · doi:10.70675/6478ae68zac8bz4d6dz994cz48cf61b11fc3
Mesenchymal stem cell-derived extracellular vesicles in cancer immunotherapy
Sanyal, A., Johnson, V., & Sukumar, U. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45056-3.00016-9
Sarcoma metastasis: distinct biological principles beyond the carcinoma paradigm
Chevalier, N., Nathan, P. C., & Stamenkovic, I. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10360-z
Metadata
- Authors
- Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., Zhang, J., Raffeld, M., Rogers, T. B., Stetler-Stevenson, W., Frank, J. A., Reitz, M., & Finkel, T.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Maryland Biotechnology Institute (US)
- National Institutes of Health (US)
- Flow Cytometry Core Facility (CH)
- 1Laboratory of Molecular Biology, Cardiovascular Branch,
- National Heart, Lung, and Blood Institute (US)
- University of Maryland, Baltimore (US)
- National Cancer Institute (UA)
- 4National Cancer Institute; and
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-04-24
- Volume
- 203
- Issue
- 5
- Pages
- 1235-1247
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2121206
- OpenAlex
- W2163234891
- Cited by
- 747
- References
- 60
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 20 · 2023: 31 · 2022: 25 · 2021: 34 · 2020: 37 · 2019: 41 · 2018: 38 · 2017: 28 · 2016: 53 · 2015: 56 · 2014: 38 · 2013: 79 · 2012: 51
- FWCI
- 14.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Cancer Institute (1R01 CA09905-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- mesenchymal stem cells, Kaposi's sarcoma, anticancer activity, Akt signaling, E-cadherin, cell-cell contact, tumor stroma, stem cell homing, tumor suppression, stem cell therapy
- MeSH terms
- Animals, Disease Models, Animal, Enzyme Activation, Male, Mice, Nude, Neoplasm Transplantation, Neoplasms, Experimental, Sarcoma, Kaposi, Transplantation, Heterologous, Tumor Cells, Cultured, Stromal Cells, Graft vs Tumor Effect, Mesenchymal Stem Cell Transplantation, Oncogene Protein v-akt, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.